Morgan Stanley’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.54K | Hold |
5,112
| – | – | ﹤0.01% | 7276 |
|
|
2025
Q1 | $1.46K | Sell |
5,112
-900
| -15% | -$256 | ﹤0.01% | 7233 |
|
|
2024
Q4 | $3.53K | Sell |
6,012
-28,000
| -82% | -$16.4K | ﹤0.01% | 7093 |
|
|
2024
Q3 | $15.2K | Buy |
34,012
+10,812
| +47% | +$4.82K | ﹤0.01% | 6593 |
|
|
2024
Q2 | $61.5K | Sell |
23,200
-19,299
| -45% | -$51.1K | ﹤0.01% | 6112 |
|
|
2024
Q1 | $116K | Sell |
42,499
-56,627
| -57% | -$155K | ﹤0.01% | 5928 |
|
|
2023
Q4 | $241K | Buy |
99,126
+37,055
| +60% | +$90K | ﹤0.01% | 5874 |
|
|
2023
Q3 | $125K | Sell |
62,071
-52,105
| -46% | -$105K | ﹤0.01% | 5776 |
|
|
2023
Q2 | $337K | Sell |
114,176
-207,201
| -64% | -$611K | ﹤0.01% | 5410 |
|
|
2023
Q1 | $803K | Buy |
321,377
+165,496
| +106% | +$414K | ﹤0.01% | 4984 |
|
|
2022
Q4 | $494K | Sell |
155,881
-41,417
| -21% | -$131K | ﹤0.01% | 5260 |
|
|
2022
Q3 | $586K | Buy |
197,298
+131,176
| +198% | +$390K | ﹤0.01% | 5187 |
|
|
2022
Q2 | $202K | Sell |
66,122
-2,670
| -4% | -$8.16K | ﹤0.01% | 5889 |
|
|
2022
Q1 | $929K | Sell |
68,792
-24,127
| -26% | -$326K | ﹤0.01% | 5050 |
|
|
2021
Q4 | $1.21M | Sell |
92,919
-85,854
| -48% | -$1.12M | ﹤0.01% | 4939 |
|
|
2021
Q3 | $1.68M | Sell |
178,773
-97,765
| -35% | -$917K | ﹤0.01% | 4713 |
|
|
2021
Q2 | $2.83M | Buy |
276,538
+254,093
| +1,132% | +$2.6M | ﹤0.01% | 4345 |
|
|
2021
Q1 | $413K | Buy |
22,445
+5,230
| +30% | +$96.2K | ﹤0.01% | 5260 |
|
|
2020
Q4 | $590K | Buy |
17,215
+16,015
| +1,335% | +$549K | ﹤0.01% | 4973 |
|
|
2020
Q3 | $22K | Buy |
+1,200
| New | +$22K | ﹤0.01% | 6021 |
|